ClinicalTrials.gov
ClinicalTrials.gov Menu

Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse (HECTOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00437307
Recruitment Status : Completed
First Posted : February 21, 2007
Last Update Posted : September 22, 2016
Sponsor:
Information provided by (Responsible Party):
North Eastern Germany Society of Gynaecologic Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2013
  Actual Study Completion Date : June 2015